Results 211 to 220 of about 37,565 (330)

Neuropsychopharmacology of hallucinogenic and non‐hallucinogenic 5‐HT2A receptor agonists

open access: yesBritish Journal of Pharmacology, EarlyView.
Psychedelic drugs such as LSD and psilocin were once relegated to the fringes of medical research because of their association with counterculture movements and a perceived concern about harm through recreational use, and their consequent legal prohibition in the early 1970s.
Trevor Sharp, Aurelija Ippolito
wiley   +1 more source

Lack of myotubularin phosphatase activity is the main cause of X-linked myotubular myopathy. [PDF]

open access: yesJCI Insight
Moschovaki-Filippidou F   +5 more
europepmc   +1 more source

Different Subcellular Localization and Phosphoinositides Binding of Insulin Receptor Substrate Protein Pleckstrin Homology Domains [PDF]

open access: bronze, 2000
Giorgia Razzini   +5 more
openalex   +1 more source

The potential for biased signalling in the P2Y receptor family of GPCRs

open access: yesBritish Journal of Pharmacology, EarlyView.
The purinergic receptor family is primarily activated by nucleotides, and contains members of both the G protein coupled‐receptor (GPCR) superfamily (P1 and P2Y) and ligand‐gated ion channels (P2X). The P2Y receptors are widely expressed in the human body, and given the ubiquitous nature of nucleotides, purinergic signalling is involved with a plethora
Claudia M. Sisk   +2 more
wiley   +1 more source

Table S3 from Co-targeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma Cells

open access: gold
Haley M. Hardin   +13 more
openalex   +1 more source

A Phosphoinositide Binding Module Controls TMEM16A Desensitization [PDF]

open access: bronze, 2019
Son C. Le   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy